News | April 12, 2024
CRISPR-based innovations drive $21 billion in pharmaceutical licensing deals over five years, reveals GlobalData
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Subscribe To Our Newsletter & Stay Updated
